David Dobarro

906 total citations
25 papers, 189 citations indexed

About

David Dobarro is a scholar working on Cardiology and Cardiovascular Medicine, Biomedical Engineering and Surgery. According to data from OpenAlex, David Dobarro has authored 25 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 9 papers in Biomedical Engineering and 7 papers in Surgery. Recurrent topics in David Dobarro's work include Mechanical Circulatory Support Devices (9 papers), Cardiac pacing and defibrillation studies (7 papers) and Cardiac Structural Anomalies and Repair (7 papers). David Dobarro is often cited by papers focused on Mechanical Circulatory Support Devices (9 papers), Cardiac pacing and defibrillation studies (7 papers) and Cardiac Structural Anomalies and Repair (7 papers). David Dobarro collaborates with scholars based in Spain, United Kingdom and Australia. David Dobarro's co-authors include Andrés Íñiguez, Sergio Raposeiras‐Roubín, Raúl Moreno, Ángel Sánchez‐Recalde, N. Wrightson, Andrew Woods, Javier Castrodeza, G. Parry, Luís Calvo and Santiago Jiménez‐Valero and has published in prestigious journals such as European Heart Journal, European Journal of Heart Failure and International Journal of Cardiology.

In The Last Decade

David Dobarro

21 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Dobarro Spain 8 105 59 44 41 25 25 189
Fabio Fazzari Italy 8 101 1.0× 50 0.8× 20 0.5× 42 1.0× 30 1.2× 22 172
Chikezie Alvarez United States 9 118 1.1× 92 1.6× 24 0.5× 68 1.7× 28 1.1× 28 261
Giulio Falasconi Italy 12 297 2.8× 70 1.2× 27 0.6× 30 0.7× 34 1.4× 57 382
Carlo Andrea Pivato Italy 11 227 2.2× 117 2.0× 16 0.4× 19 0.5× 17 0.7× 34 328
Valeria Donghi Italy 5 165 1.6× 20 0.3× 41 0.9× 42 1.0× 11 0.4× 9 213
Lior Lupu Israel 9 118 1.1× 35 0.6× 14 0.3× 37 0.9× 21 0.8× 48 231
Süha Asal Türkiye 10 128 1.2× 36 0.6× 10 0.2× 86 2.1× 38 1.5× 19 267
Hannah Schaubroeck Belgium 9 52 0.5× 51 0.9× 47 1.1× 31 0.8× 29 1.2× 25 198
Armando Coca Spain 8 49 0.5× 51 0.9× 10 0.2× 31 0.8× 17 0.7× 23 152
Gil Bonet Spain 10 132 1.3× 29 0.5× 8 0.2× 55 1.3× 24 1.0× 31 261

Countries citing papers authored by David Dobarro

Since Specialization
Citations

This map shows the geographic impact of David Dobarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dobarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dobarro more than expected).

Fields of papers citing papers by David Dobarro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Dobarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dobarro. The network helps show where David Dobarro may publish in the future.

Co-authorship network of co-authors of David Dobarro

This figure shows the co-authorship network connecting the top 25 collaborators of David Dobarro. A scholar is included among the top collaborators of David Dobarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Dobarro. David Dobarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dobarro, David, María G. Crespo‐Leiro, Sergio Raposeiras‐Roubín, et al.. (2024). Guideline-Directed Medical Therapy for Heart Failure in Arrhythmia-Induced Cardiomyopathy with Improved Left Ventricular Ejection Fraction. European Journal of Heart Failure. 27(3). 442–452. 3 indexed citations
2.
Dobarro, David, et al.. (2023). Home exercise intervention with the Vivifrail program in frail older patients with heart failure with reduced ejection fraction. The ExFRAIL-HF randomized trial. Revista Española de Cardiología (English Edition). 76(11). 939–943. 3 indexed citations
4.
Pascual‐Figal, Domingo A., J. L. Zamorano, Mar Domingo, et al.. (2023). Impact of Dapagliflozin on Cardiac Remodelling in Patients with Chronic Heart Failure: The DAPA-MODA Study. European Journal of Heart Failure. 25(8). 1352–1360. 31 indexed citations
5.
Codina, Pau, David Dobarro, Javier de Juan Bagudá, et al.. (2023). Heart Failure Risk Scores in Advanced Heart Failure Patients: Insights from the LEVO-D Registry. ESC Heart Failure. 10(5). 2875–2881. 1 indexed citations
6.
Dobarro, David, Álvaro Marchán-López, Sergio Raposeiras‐Roubín, et al.. (2023). Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?. International Journal of Cardiology. 386. 59–64. 1 indexed citations
7.
Dobarro, David, et al.. (2023). Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection. Life. 13(4). 1065–1065. 7 indexed citations
8.
Dobarro, David. (2020). Pronóstico actual de la insuficiencia cardiaca en España y Europa. Una llamada de atención. REC CardioClinics. 55(4). 201–203. 1 indexed citations
9.
Dobarro, David, et al.. (2020). Ambulatory levosimendan infusions. Effective and efficient in advanced heart failure?. Revista Española de Cardiología (English Edition). 73(5). 345–347.
10.
Dobarro, David, Carles Díez‐López, David Couto‐Mallón, et al.. (2020). Use of sacubitril-valsartan in blood pressure control with left ventricular assist devices. The Journal of Heart and Lung Transplantation. 39(12). 1499–1501. 7 indexed citations
11.
Dobarro, David, et al.. (2020). Durable left ventricular assist device therapy in non transplant centers in Spain: initial experience. Revista Española de Cardiología (English Edition). 73(4). 338–340. 1 indexed citations
12.
Dobarro, David, et al.. (2020). Multivessel coronary thrombosis in a patient with COVID-19 pneumonia. European Heart Journal. 41(22). 2132–2132. 48 indexed citations
13.
Dobarro, David, Carmen Martín, Carlos Alberto Gurgel Veras, et al.. (2019). Exercise right heart catheterization predicts outcome in asymptomatic degenerative aortic stenosis. Revista Española de Cardiología (English Edition). 73(6). 457–462. 4 indexed citations
14.
Dobarro, David, et al.. (2019). Dispositivos de asistencia ventricular izquierda de larga duración en centros no trasplantadores en España: experiencia inicial. Revista Española de Cardiología. 73(4). 338–340. 1 indexed citations
15.
Dobarro, David, Carmen Martín, Carlos Alberto Gurgel Veras, et al.. (2019). El cateterismo cardiaco derecho de esfuerzo predice eventos en los pacientes con estenosis aórtica degenerativa asintomática. Revista Española de Cardiología. 73(6). 457–462. 3 indexed citations
16.
Castrodeza, Javier, Ashley Woods, David Dobarro, et al.. (2018). Infection Predisposes to Thrombosis During Long Term VAD Support. The Journal of Heart and Lung Transplantation. 37(4). S362–S363.
17.
Dobarro, David, Marian Urban, Karen Booth, et al.. (2016). Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device. The Journal of Heart and Lung Transplantation. 36(1). 42–49. 27 indexed citations
18.
Moreno, Raúl, et al.. (2010). Estenosis aórtica grave en situación crítica. Medicina Intensiva. 36(7). 513–515.
19.
Dobarro, David, et al.. (2009). Current Pharmacological Approach to Restore Endothelial Dysfunction. Cardiovascular & Hematological Agents in Medicinal Chemistry. 7(3). 212–222. 19 indexed citations
20.
Dobarro, David, Ángel Sánchez‐Recalde, Montserrat Bret Zurita, et al.. (2008). Chagas' heart disease in Europe: an emergent disease?. Journal of Cardiovascular Medicine. 9(12). 1263–1267. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026